Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Growth/Differentiation Factor 8 Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Growth/Differentiation Factor 8 Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 OSX-200
      • 1.3.3 SRK-015
      • 1.3.4 ACE-2494
      • 1.3.5 ACE-2798
      • 1.3.6 BMS-986089
      • 1.3.7 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Growth/Differentiation Factor 8 Market Share by Application (2019-2025)
      • 1.4.2 Becker Muscular Dystrophy
      • 1.4.3 Fibrosis
      • 1.4.4 Myelofibrosis
      • 1.4.5 Sickle Cell Disease
      • 1.4.6 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Growth/Differentiation Factor 8 Market Size
      • 2.1.1 Global Growth/Differentiation Factor 8 Revenue 2014-2025
      • 2.1.2 Global Growth/Differentiation Factor 8 Sales 2014-2025
    • 2.2 Growth/Differentiation Factor 8 Growth Rate by Regions
      • 2.2.1 Global Growth/Differentiation Factor 8 Sales by Regions 2014-2019
      • 2.2.2 Global Growth/Differentiation Factor 8 Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Growth/Differentiation Factor 8 Sales by Manufacturers
      • 3.1.1 Growth/Differentiation Factor 8 Sales by Manufacturers 2014-2019
      • 3.1.2 Growth/Differentiation Factor 8 Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Growth/Differentiation Factor 8 Revenue by Manufacturers (2014-2019)
      • 3.2.2 Growth/Differentiation Factor 8 Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Growth/Differentiation Factor 8 Market Concentration Ratio (CR5 and HHI)
    • 3.3 Growth/Differentiation Factor 8 Price by Manufacturers
    • 3.4 Key Manufacturers Growth/Differentiation Factor 8 Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Growth/Differentiation Factor 8 Market
    • 3.6 Key Manufacturers Growth/Differentiation Factor 8 Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 OSX-200 Sales and Revenue (2014-2019)
      • 4.1.2 SRK-015 Sales and Revenue (2014-2019)
      • 4.1.3 ACE-2494 Sales and Revenue (2014-2019)
      • 4.1.4 ACE-2798 Sales and Revenue (2014-2019)
      • 4.1.5 BMS-986089 Sales and Revenue (2014-2019)
      • 4.1.6 Others Sales and Revenue (2014-2019)
    • 4.2 Global Growth/Differentiation Factor 8 Sales Market Share by Type
    • 4.3 Global Growth/Differentiation Factor 8 Revenue Market Share by Type
    • 4.4 Growth/Differentiation Factor 8 Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Growth/Differentiation Factor 8 Sales by Application

    6 United States

    • 6.1 United States Growth/Differentiation Factor 8 Breakdown Data by Company
    • 6.2 United States Growth/Differentiation Factor 8 Breakdown Data by Type
    • 6.3 United States Growth/Differentiation Factor 8 Breakdown Data by Application

    7 European Union

    • 7.1 European Union Growth/Differentiation Factor 8 Breakdown Data by Company
    • 7.2 European Union Growth/Differentiation Factor 8 Breakdown Data by Type
    • 7.3 European Union Growth/Differentiation Factor 8 Breakdown Data by Application

    8 China

    • 8.1 China Growth/Differentiation Factor 8 Breakdown Data by Company
    • 8.2 China Growth/Differentiation Factor 8 Breakdown Data by Type
    • 8.3 China Growth/Differentiation Factor 8 Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Growth/Differentiation Factor 8 Breakdown Data by Company
    • 9.2 Rest of World Growth/Differentiation Factor 8 Breakdown Data by Type
    • 9.3 Rest of World Growth/Differentiation Factor 8 Breakdown Data by Application
    • 9.4 Rest of World Growth/Differentiation Factor 8 Breakdown Data by Countries
      • 9.4.1 Rest of World Growth/Differentiation Factor 8 Sales by Countries
      • 9.4.2 Rest of World Growth/Differentiation Factor 8 Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Acceleron Pharma, Inc.
      • 10.1.1 Acceleron Pharma, Inc. Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Growth/Differentiation Factor 8
      • 10.1.4 Growth/Differentiation Factor 8 Product Introduction
      • 10.1.5 Acceleron Pharma, Inc. Recent Development
    • 10.2 Atara Biotherapeutics, Inc.
      • 10.2.1 Atara Biotherapeutics, Inc. Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Growth/Differentiation Factor 8
      • 10.2.4 Growth/Differentiation Factor 8 Product Introduction
      • 10.2.5 Atara Biotherapeutics, Inc. Recent Development
    • 10.3 Bristol-Myers Squibb Company
      • 10.3.1 Bristol-Myers Squibb Company Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Growth/Differentiation Factor 8
      • 10.3.4 Growth/Differentiation Factor 8 Product Introduction
      • 10.3.5 Bristol-Myers Squibb Company Recent Development
    • 10.4 Eli Lilly and Company
      • 10.4.1 Eli Lilly and Company Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Growth/Differentiation Factor 8
      • 10.4.4 Growth/Differentiation Factor 8 Product Introduction
      • 10.4.5 Eli Lilly and Company Recent Development
    • 10.5 Milo Biotechnology LLC
      • 10.5.1 Milo Biotechnology LLC Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Growth/Differentiation Factor 8
      • 10.5.4 Growth/Differentiation Factor 8 Product Introduction
      • 10.5.5 Milo Biotechnology LLC Recent Development
    • 10.6 Pfizer Inc.
      • 10.6.1 Pfizer Inc. Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Growth/Differentiation Factor 8
      • 10.6.4 Growth/Differentiation Factor 8 Product Introduction
      • 10.6.5 Pfizer Inc. Recent Development
    • 10.7 Regeneron Pharmaceuticals, Inc.
      • 10.7.1 Regeneron Pharmaceuticals, Inc. Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Growth/Differentiation Factor 8
      • 10.7.4 Growth/Differentiation Factor 8 Product Introduction
      • 10.7.5 Regeneron Pharmaceuticals, Inc. Recent Development
    • 10.8 Sarepta Therapeutics, Inc.
      • 10.8.1 Sarepta Therapeutics, Inc. Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Growth/Differentiation Factor 8
      • 10.8.4 Growth/Differentiation Factor 8 Product Introduction
      • 10.8.5 Sarepta Therapeutics, Inc. Recent Development
    • 10.9 Scholar Rock, Inc.
      • 10.9.1 Scholar Rock, Inc. Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Growth/Differentiation Factor 8
      • 10.9.4 Growth/Differentiation Factor 8 Product Introduction
      • 10.9.5 Scholar Rock, Inc. Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Growth/Differentiation Factor 8 Sales Channels
      • 11.2.2 Growth/Differentiation Factor 8 Distributors
    • 11.3 Growth/Differentiation Factor 8 Customers

    12 Market Forecast

    • 12.1 Global Growth/Differentiation Factor 8 Sales and Revenue Forecast 2019-2025
    • 12.2 Global Growth/Differentiation Factor 8 Sales Forecast by Type
    • 12.3 Global Growth/Differentiation Factor 8 Sales Forecast by Application
    • 12.4 Growth/Differentiation Factor 8 Forecast by Regions
      • 12.4.1 Global Growth/Differentiation Factor 8 Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Growth/Differentiation Factor 8 Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Growth/Differentiation Factor 8 is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Growth/Differentiation Factor 8.

      This report studies the global market size of Growth/Differentiation Factor 8, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Growth/Differentiation Factor 8 sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Acceleron Pharma, Inc.
      Atara Biotherapeutics, Inc.
      Bristol-Myers Squibb Company
      Eli Lilly and Company
      Milo Biotechnology LLC
      Pfizer Inc.
      Regeneron Pharmaceuticals, Inc.
      Sarepta Therapeutics, Inc.
      Scholar Rock, Inc.

      Market Segment by Product Type
      OSX-200
      SRK-015
      ACE-2494
      ACE-2798
      BMS-986089
      Others

      Market Segment by Application
      Becker Muscular Dystrophy
      Fibrosis
      Myelofibrosis
      Sickle Cell Disease
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Growth/Differentiation Factor 8 status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Growth/Differentiation Factor 8 manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Growth/Differentiation Factor 8 are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now